Planar cell polarity (PCP) is a common feature of many epithelia and epithelial organs. Although progress has been made in the dissection of molecular mechanisms regulating PCP, many questions remain. Here we describe a screen to identify novel PCP regulators in Drosophila. We employed mild gain-of-function (GOF) phenotypes of two cytoplasmic Frizzled (Fz)/PCP core components, Diego (Dgo) and Prickle (Pk), and screened these against the Drosdel genome wide deficiency collection for dominant modifiers. Positive genomic regions were rescreened and narrowed down with smaller overlapping deficiencies from the Exelixis collection and RNAi-mediated knockdown applied to individual genes. This approach isolated new regulators of PCP, which were confirmed with loss-offunction analyses displaying PCP defects in the eye and/or wing. Furthermore, knockdown of a subset was also sensitive to dgo dosage or dominantly modified a dishevelled (dsh) GOF-phenotype, supporting a role in Fz/PCP-mediated polarity establishment. Among the new "PCP"-genes we identified several kinases, enzymes required for lipid modification, scaffolding proteins, and genes involved in substrate modification and/or degradation. Interestingly, one of them is a member of the Meckel-Gruber Syndrome factors, associated with human ciliopathies, suggesting an important role for cell polarity in non-ciliated cells.
Introduction
Planar cell polarity (PCP) controls the orientation of single cells or groups of cells within a plane of tissue and is conserved throughout the animal kingdom (BAYLY and AXELROD 2011; SEIFERT and MLODZIK 2007; WANG and NATHANS 2007) . In Drosophila, for example, PCP manifests in each wing cell as a single distally pointing hair, or in the compound eye in the arrangement of photoreceptor cells (ADLER 2002; KLEIN and MLODZIK 2005; SEIFERT and MLODZIK 2007; STRUTT 2003) . When PCP establishment is perturbed in the wing, hairs can point in random directions and/or several wing hairs form in single cells. In the eye, PCP controls two aspects of ommatidial orientation: photoreceptor R3 and R4 cell fate determination and a subsequent 90 o rotation of an entire ommatidium, which together establish a mirror image symmetry along the D/V boundary, the equator (MLODZIK 1999; STRUTT and STRUTT 1999) . In this context, PCP defects can produce random chiral arrangements of photoreceptors, symmetrical, and misrotated ommatidia (ADLER 2002; KLEIN and MLODZIK 2005; SEIFERT and MLODZIK 2007; STRUTT 2003) .
A conserved core set of proteins is critical for PCP establishment. These include the multi-pass trans-membrane proteins Frizzled (Fz), Strabismus/Van Gogh (Stbm/Vang), and Flamingo/Starry night (Fmi/Stan, an atypical cadherin), and the cytoplasmic factors Dishevelled (Dsh), Prickle (Pk), and Diego (Dgo) (ADLER 2002; BAYLY and AXELROD 2011; KLEIN and MLODZIK 2005; SEIFERT and MLODZIK 2007; STRUTT 2003; WANG and NATHANS 2007) . The Fz receptor recruits and signals through Dsh, a component shared with the canonical wingless (wg)/Wnt signaling pathway (BOUTROS and MLODZIK 1999; WALLINGFORD and HABAS 2005) . The other core PCP factors are thought to regulate Fz-Dsh activity and/or localization: Dgo promotes Fz-Dsh complex formation, whereas Stbm/Vang and Pk antagonize it (JENNY et al. 2005; TREE et al. 2002) ; Fmi/Stan is thought to promote the function of both complexes by stabilizing their membrane association (CASAL et al. 2006; CHEN et al. 2008; DAS et al. 2002; KLEIN and MLODZIK 2005; LAWRENCE et al. 2004; SAHAI et al. 1998; STRUTT and STRUTT 2008; STRUTT and STRUTT 2009; USUI et al. 1999) . As a result of their interactions, the core components localize asymmetrically in Drosophila tissues, forming two complexes on opposite sides of any given cell. In the wing, Stbm/Vang and Pk accumulate in complexes on the proximal side of each cell, whereas Fz, Dsh and Dgo form a complex that localizes distally. Fmi/Stan is part of both complexes (CASAL et al. 2006; CHEN et al. 2008; KLEIN and MLODZIK 2005; LAWRENCE et al. 2004; STRUTT and STRUTT 2009) . Whereas the interactions among the core factors are beginning to be understood, less is known about potential upstream long-range signaling input or downstream cellular interactions/effectors of the complexes.
Besides the Fz/PCP core group, a parallel pathway anchored around the protocadherins Fat (Ft) and Dachsous (Ds) also acts in PCP establishment (CASAL et al. 2006; LAWRENCE et al. 2007 ). In certain contexts Fat/Ds and Fz/PCP signaling act redundantly, though the exact relationship between these pathways remains unclear (CASAL et al. 2006; DONOUGHE and DINARDO 2011) . Similarly, although apical-basal (A/B)-polarity determinants can interact with Fz/PCP factors (COURBARD et al. 2009; DJIANE et al. 2005) and A/B-polarity in epithelia is generally a prerequisite for PCP-type polarity, interactions among A/B-polarity factors and PCP core components are not well defined.
To gain insight into the regulatory interactions among the core Fz/PCP genes, their relationship with other polarity determinants, and to identify novel effectors of the core PCP complexes, we designed a genetic screen employing mild core PCP factor overexpression. We selected Pk and Dgo, because they act at the level of Dsh, compete for Dsh binding in vitro, and antagonize each other in the context of PCP establishment (JENNY et al. 2005) . Gain-of-function (GOF) backgrounds of Dgo and
Pk were used in a genome-wide modifier screen to select for genetic interactions with both complexes.
Furthermore, we took advantage of several recently available genetic tools in Drosophila: collections of overlapping deficiencies generated by recombinant techniques in genetically identical animals, including the DrosDel (RYDER et al. 2007) and Exelixis (PARKS et al. 2004) 
Methods

Fly stocks and genetic screen
Recombinants of Rh1-GFP, sev-GAL4 and UAS-dgo or UAS-pk sple (the Sple isoform of Pk (GUBB et al. 1999; JENNY et al. 2005 ) (referred to as sev-GAL4, UAS-dgo or sev-GAL4, UAS-pk, respectively)
were established and tested for reproducible chirality and ommatidial rotation defects. Testcrosses to pk 13 and pk sple1 alleles revealed that the w; UAS-dgo, Rh1-GFP; sev-GAL4 recombinant flies carry a strong pk (pk-sple) mutation originating from the Rh1-GFP chromosome, affecting all adult tissues.
The sev-GAL4 driver (expressed during PCP establishment in a subset of R-cells including the R3/R4 precursors) has basal expression in other tissues due to the presence of a heat-shock promoter (from hsp70 , dgo, dsh, fat, ds, scrb, l(2)gl, aPKC, nmo/Nlk, and Notch (for alleles see above).
In the deficiency screen, 32% of the DrosDel deficiencies (RYDER et al. 2007) showed an external modification. 5.6% of these were excluded due to non-PCP effects in the Rh1-GFP assay. Regions of the genome that showed robust modification in 2 independent experiments were further screened with UAS-RNAi lines were obtained from VDRC (DIETZL et al. 2007 ) and the NIG-Fly Stock Centers. All other stocks were received from the Bloomington stock center.
Imaging and Histology
Adult flies were initially inspected and evaluated on a Zeiss stereo microscope at 66x magnification for external eye and wing phenotype modification. The internal rhabdomere pattern was documented on a Zeiss Axioscope2 plus with a 40x water immersion lens at 400x magnification with UV light illumination. Concentric pictures of 4 individual eyes were evaluated and a total of 80-160 ommatidia were scored independently for rotation and chirality defects and statistically analyzed by t-test. Wings were mounted in 80% glycerol in 1x PBS (WU et al. 2004 ) and wing hair orientation defects analyzed for both surfaces of 4 to 10 wings. Tangential eye sections were prepared as described (TOMLINSON and READY 1987) .
Results
Establishment of genotypes and pilot screen
Several genetic modifier screens addressing PCP have been performed in the past with a focus on the trans-membrane proteins fz and stbm/Vang (for example: (RAWLS and WOLFF 2003; STRUTT and STRUTT 2003) , while the cytoplasmic components have been less explored. In particular, dgo and pk
have not yet been used as screening tools, but are of specific interest due to their antagonistic relationship and opposing effects on Fz-Dsh/PCP signaling (JENNY et al. 2005) .
To identify new regulatory factors related to PCP establishment that could either act on Dgo or Pk, affect Fz-Dsh/PCP signaling in general, or also function as effectors of the PCP-pathway, we employed the GAL4-UAS system (BRAND and PERRIMON 1993) to overexpress Dgo and Pk. In order to screen both eye and wing tissues, we used a sevenless (sev-enhancer) heat-shock (hs)-promoter-GAL4 (see Methods) (BASLER et al. 1989 ) that drives expression in the eye transiently at high levels in the R3/R4 photoreceptor precursor pair at a time when PCP is being established (BOUTROS et al. 1998; STRUTT et al. 1997) and at low levels in other tissues including the wing (due to the presence of basal level of expression from the hs-promoter, Fig. 2C,D) . In order to test whether these genotypes were sensitive and specific enough for such an assay, we tested mutant alleles (see Methods) of the known Fz/PCP core components (rev. in (ADLER 2002; KLEIN and MLODZIK 2005; SEIFERT and MLODZIK 2007; STRUTT 2003) , the parallel acting Fat/Ds PCP pathway (CASAL et al. 2006; LAWRENCE et al. 2007; MATAKATSU and BLAIR 2004; SIMON et al. 2010) , or the apico-basal (A/B)-polarity factors that are known to interact with PCP proteins (COURBARD et al. 2009; DJIANE et al. 2005 ). Furthermore, we tested the consistency of our imaging and scoring methods by examining the rhodopsin1-GFP rhabdomere marker (PICHAUD and DESPLAN 2001)(see Methods) for PCP-associated rhabdomere orientation defects ( Fig. 1A-F ) and hair orientation defects by microscopic inspection (Fig. 2C-F) . In sev-GAL4, UAS-dgo and sev-GAL4, UAS-pk eyes (referred to as the screen genotypes), ommatidia showed chirality and rotation defects (Fig. 1B , E, F and see Methods). In sev-GAL4, UASdgo wings, cellular hairs were misoriented in the region between the anterior wing margin and longitudinal vein L3 (Fig. 2D ), while in sev-GAL4, UAS-pk wing hairs were partially misoriented between L2 and L3 on one surface (Fig. 2C ).
In the pilot screen, among the core PCP factors, removing a copy of stbm/Vang enhanced (JENNY et al. 2005) and of fmi/stan suppressed both eye and wing defects significantly (Fig. 1C , D, F, and 2D-G). The fact that stbm/Vang modified the dgo GOF background is consistent with earlier data (JENNY et al. 2005) . The observation that fmi/stan acted as a dominant suppressor in both tissues and the genetic effect of fmi/stan acting in opposition to stbm/Vang has not been observed but is consistent with current models (see Discussion). Of the other "PCP-related genes" tested, we observed that some but not all alleles of ds and Delta (Dl), acting in R3/R4 specification (COOPER and BRAY 1999; FANTO and MLODZIK 1999; TOMLINSON and STRUHL 1999) presumably further abolished the difference between R3 and R4 cell fate and therefore enhances PCP chirality defects (Fig. 1F ). The Aop/Yan transcription factor is required in photoreceptor R3 to inhibit R4 fate (WEBER et al. 2008) . Here, reduction of aop/yan function in the context of dgo overexpression further reduced the cell fate difference between R3 and R4, causing more severe PCP defects ( Fig. 1F ). Negative controls showed no effect in this assay ( Taken together, we have established effective tools to screen for novel PCP factors, which are both sensitive enough to identify suppressor and enhancer-type interactions, but also stringent enough to only detect specific modifiers in the eye and the wing. We therefore utilized this set of tools to screen the genome of Drosophila melanogaster for new PCP regulators by lowering the copy number of gene intervals with deficiencies generated by Drosdel (RYDER et al. 2007 ).
Deficiency Screen
To identify new PCP regulatory factors, we screened both genotypes, sev-GAL4, UAS-Dgo and sev-GAL4, UAS-Pk (see Methods for details), testing these against the DrosDel deficiency collection for dominant modifications. In the primary screening, we examined the external appearance of adult compound eyes and wings for phenotypic suppression or enhancement (Table 1 , Fig. 3 ). For deficiencies displaying robust external modification(s) in either tissue, we examined in detail PCP orientation in the eye, using the internal Rh1-GFP rhabdomere pattern, and wing hair orientation patterns in mounted wings (Table 1) . 195 deficiencies were screened in this manner, covering ~80% of the genome. Of these, 21% modified the internal PCP eye phenotype and 21% modified the wing phenotype. 11% showed effects in both tissues and 8.5% affected both genotypes. (Table 1 ) Those deficiencies affecting both genotypes were considered high priority candidates and were analyzed further. 68% of the deficiencies did not show an effect (listed in Supplemental Table S1 ).
The initial genomic region responsible for an interaction was narrowed down by using smaller, subdividing deficiencies from the Exelixis collection (PARKS et al. 2004) or partially overlapping cytologically mapped deficiencies ( Fig. 3 and 4) . The same Rh1-GFP eye patterning analysis was used to confirm and refine the genomic region of interaction (see Fig. 1 ). Many initially defined interactions were confirmed by such rescreening with smaller deficiencies (Table 2 , example shown in Fig. 4A ). In a small number of cases, however, we could not isolate the interaction in that manner, e.g. the large deficiency was fully covered by subdividing deficiencies, but none of these reproduced the original interaction ( Fig. S1 ), which was consistent with data observed in the pilot screen (Fig. 1F , see above). We did not recover other known PCP genes in the deficiency screen (see Discussion).
Since pk and dgo act at the level of dsh, we further tested if any of the identified deficiencies (Table 1) interacted with sev-dsh (BOUTROS et al. 1998) in the eye. Unfortunately, the Rh1-GFP rhabdomere pattern did not resolve into sharp pictures in this genetic background and therefore only external modifications could be used as selection criteria. Two deficiencies, Df(2L)ED793 and ED(3R)5644 displayed an interaction and were confirmed by eye sections to be suppressors of sev-dsh (Suppl. Fig. S2 ).
In analogy, we also tested for modifications of sev-fz, Rh1-GFP, but none of the isolated deficiencies displayed a strong modification of this background.
For further analysis, we focused on the interacting genomic regions that showed an effect with both screen genotypes and/or in both tissues.
Identification and loss-of-function analyses of new PCP candidate regulators
The narrowing-down of the initial genomic regions via subsequent screening with smaller deficiencies allowed us to define a small set of potential candidate genes for most interacting regions ( Fig. 3 and Table 2 ). These were then tested individually, each with UAS-RNAi transgenic flies in direct LOF function studies for PCP defects. Each candidate gene was first analyzed microscopically for eye PCP defects, with UAS-RNAi, sev-GAL4, Rh1-GFP. In order to increase the phenotypes observed, further crosses were set up in combination with UAS-dcr2, or the copy numbers of the GAL4/UAS constructs and/or the temperature were increased. Such flies were then analyzed in more detail in adult eye sections (Fig. 5 ). For phenotypic analyses in the wing, specific GAL4 drivers (see Methods) were used in combinations as described above for the eye (Table 3 ). The individual genes that showed PCP related LOF defects were then tested via UAS-RNAi in the original genetic backgrounds employed in the screen to confirm that the interaction within a given genomic region was caused by gene dosage reduction of the respective factor (Table 2) . In this manner, within the 13
DrosDel deficiencies identified originally, we confirmed and isolated the interaction to 11 individual genes (Table 2) .
Phenotypes observed in the eye included classical PCP defects represented by either rotation (Fig.   5F ) or chirality ( Fig. 5H ) defects, or both ( Fig. 5A -B, D); they often occurred in combination with loss of photoreceptors, which is also observed in dsh LOF eyes, for example (BOUTROS et al. 1998) . In the wing, phenotypic analyses again revealed classical PCP defects, like misoriented cellular hairs (Fig. 6 D, I) and/or clustered wing hairs ( Fig. 6E-H ). In addition, we observed wing margin defects/notches ( Fig. 6A-B ) and vein defects (Fig. 6C) . Both of the latter phenotypes might be associated with Notch-signaling (see Discussion). Most genes identified in this screen affected PCP in both tissues, the eye and wing, and few affected only one of the tissues (Table 3 ).
The molecular nature and features of these new PCP regulatory genes ranged from kinases, phosphatases, enzymes required for lipid biosynthesis or modification, to proteins involved in substrate degradation or modification. Among the kinases, CG7004 (four wheel drive/fwd) encodes a PI4kinaseß, which has been shown to be required for male germ line development (POLEVOY et al. 
Genetic interactions with core PCP factors and Notch
The screen identified new PCP regulators as modifiers of a dgo or pk GOF phenotype. We also isolated factors that potentially modulate Notch signaling, as a few candidates showed notches or wing vein defects when knocked down with UAS-RNAi ( Fig. 6A-C ; Table 3 ). As Notch signaling interacts with Fz/PCP core factors in the eye via Dl upregulation (and Dl was indeed one of the genes identified in the screen) this was consistent. We thus tested these candidate genes in a Notch-/+ background.
However, we did not observe an enhancement of the UAS-RNAi induced eye or wing margin/vein phenotype in a Notch heterozygous background.
To get further insight into the potential role(s) of the newly identified PCP regulatory factors and/or to corroborate that some of them might act at the level of dgo, pk, and dsh within the PCP hierarchy, we next tested whether their function was sensitive to endogenous levels of dgo, pk, or dsh.
To this end UAS-RNAi; GAL4 stocks of the respective genes (with an eye or wing specific GAL4 driver, see above) were analyzed for genetic requirements by crossing these to dgo, pk, dsh, fat and ds mutants. Two genes were sensitive to halving the genomic dose of dgo and showed an enhancement of PCP defects in a heterozygous dgo background: CG15730 and CG15283 in the wing (Fig. 7) . The others did not display an equivalent interaction with either dgo or the other genes tested. Intercrossing UAS-RNAi transgenes of the new candidate PCP regulators/modifiers that caused similar wing defects or fell into similar molecular function classes did not reveal specific enhancements, suggesting that they are not clustered functionally within a molecular complex.
The enhancement of CG15283 by dgo heterozygosity was particularly robust (Fig. 7B and F) and thus we tested whether dsh, the genetic and molecular binding partner of dgo, also displayed interactions with CG15283. To this end we used dsh GOF and LOF eye phenotypes (as these are dosage sensitive and quantifiable) and asked whether levels of CG15283 affect these. Strikingly, the sev-Dsh GOF phenotype is markedly suppressed by lowering the CG15283 function via RNAi (Fig.   8A -B and E) and comparable to the effect seen with Df(2L)ED793, which led us to identify CG15283 (Suppl. Fig. S2) . Accordingly, the PCP-specific hypomorphic dsh 1 loss-of-function allele phenotype is strongly enhanced by sevGAL4, CG15283 IR gene knock down (Fig. 8C-D and F) . Thus, in both genetic scenarios CG15283 promotes Dsh function, being positively required for Dsh (this conclusion is also consistent with its genetic interactions in the original screen genotypes; see above).
gish/CK1γ regulates ommatidial rotation
Phenotypic analyses of CG6963, the gene encoding CK1γ (gilgamesh/gish in Drosophila) revealed specific features in eye PCP establishment. Moderate gene knock-down of CG6963/gish appeared to primarily affect ommatidial rotation (Fig. 9A) . Stronger knock-down of gish caused additional defects in photoreceptor specification including rare symmetrical ommatidia and R-cell loss (Fig. 5J) To get more insight into the potential role of gish in ommatidial rotation, we (1) wished to confirm and refine the rotation phenotype in 3 rd instar imaginal discs during the actual process by analyzing a gish LOF allele and (2) tested for genetic interactions with other genes involved in ommatidial rotation. First, analyses of LOF clones in eye imaginal discs revealed that many clusters are underrotated in gish mutant tissue (Fig. 9D-D" ).
Second, we asked whether a gish knock-down can affect other genes involved in ommatidial rotation. Among the core PCP factors, RNAi-mediated gish knock down enhanced sev-Fmi ( Fig. 9C-B ; quantif. in Suppl. Fig. S3B ) and sevG4, UAS-Fz (not shown), in both cases the enhancement was specific to the rotation defects observed. This is consistent with the interaction detected in the original screen genotype (a GOF dgo background) and suggested a specific role of gish in ommatidial rotation.
Next we asked whether any of the "rotation specific PCP genes", including nemo (nmo, Nlk in mammals) (CHOI and BENZER 1994; FIEHLER and WOLFF 2008; MIRKOVIC et al. 2011 Fig. 9G , see also Suppl. Fig. S3B for quantification). These data suggest that Gish/CK1g acts in opposition to Nmo/Nlk, and that a fine balance between the activities of these two kinases is required for normal ommatidial rotation to occur.
Discussion
Here we described a genetic screen to identify novel modifiers and regulatory factors linked to Fz/PCP signaling. We have used two mild GOF backgrounds of the cytosolic core components Dgo and Pk as screening tools, because they act antagonistically within the core Fz/PCP cassette. The screen relied on dosage sensitive interactions, a frequently used feature of mild PCP overexpression/GOF phenotypes (BOUTROS et al. 1998; STRUTT et al. 1997; STRUTT and STRUTT 2003) , and we used a combination of deficiency collections and transgenic RNAi strains to identify new PCP regulators.
We first tested the genotypes of interest in a pilot screen with known PCP factors, other associated signaling pathway components (e.g Dl), and negative controls. The positive candidates from the pilot screen indicated that the phenotypes were well within the appropriate sensitivity range for a dosage dependent screen. In particular, the fact that stbm/Vang enhanced the dgo GOF phenotype supports previous studies and the existing model that Dgo promotes Fz-Dsh signaling activity, whereas stbm/Vang antagonizes it (JENNY et al. 2005) . The fact that stan/+ suppressed the dgo GOF phenotype is novel, but consistent with existing models, as Stan/Fmi is thought to contribute to anchoring Dgo at the membrane as part of the Fz-Dsh complex (DAS et al. 2004; FEIGUIN et al. 2001; STRUTT and STRUTT 2007; WU et al. 2008) .
Our genome wide screen has identified a set of genes with a broad range of functions, some of which were known to affect PCP (ds and Dl, see above for references) and a group of novel genes in the PCP context (see below). Generally, most of the genes identified were "hits" associated with dgo, and several of these not only modified the dgo GOF phenotype, but were also enhanced by dgo heterozygosity when knocked down via RNAi (Fig. 7) . We trust that all the genes identified via RNAi are specific (and not due to potential off-target effects), as they largely reproduced the genetic interaction(s) seen with the deficiencies (Table 2 ). As we narrowed down the genomic areas responsible for the genetic interactions, we sometimes observed that the quality of a genetic effect changed. This could be due to separating several independent interacting genes that were initially causing an "additive effect" within the larger deficiencies or by separating genomic regulatory sequences that modify effects (Fig. 4A , Table 2 , and Suppl. Fig. S1 ).
Through the design of the screen we not only isolated dosage sensitive interactors, but our approach directly lead to the identification of genes that display PCP phenotypes in a loss-of-function (knock down) scenario. As such every new gene isolated is indeed required for PCP establishment and most of them act in eye and wing tissue, suggesting a general requirement. There might be tissue specific hits in our screen (Table 1) , which have not yet been characterized.
Besides pk, we were not able to identify other core Fz/PCP genes in the deficiency screen that showed a dose dependent interaction in the pilot screen (Vang/stbm and stan/fmi). A possible explanation is that a single deficiency can harbor genes that act antagonistically and thus neutralize each other in a modification assay, e.g. fmi/stan resides near other genes that can affect PCP (e.g. dgo and pipsqueak/psq; (FEIGUIN et al. 2001; WEBER et al. 2008; WEBER et al. 1995) and no interaction was seen with deficiency Df(2R)ED2098, which removes fmi/stan. Several of the newly identified genes fall into interesting functional categories that are either novel within the PCP regulatory machinery or may provide insight into new regulatory mechanisms. These include for example lipid modifications, factors associated with mammalian ciliopathies, and, presumably, protein stability/trafficking via ubiquitination (see below).
Functional features of new PCP regulators
The Pk, which promote and antagonize Dsh function, respectively. Structure-function studies will be needed to reveal the molecular features of CG15283.
Three isolated genes fall into the category of scaffold proteins, CG1019 (Mlp1, a LIM domain containing protein), CG11146 (an SH2-SH3 domain containing factor), and CG13388 (Drosophila Akap200). Scaffold proteins are common factors in protein complexes and thus the formation or stabilization of a PCP-specific complex or an associated complex is likely to require other such proteins. Akap200, although by name a PKA associated factor in some contexts, also has non-PKA mediated functions (JACKSON and BERG 2002) and thus could well be involved in Fz/PCP signaling.
CG6963 is Drosophila CK1γ, called gilgamesh (gish) in flies. Members of the Casein Kinase 1 family have been implicated in several aspects of canonical Wnt-signaling (DAVIDSON et al. 2005; KLEIN et al. 2006; STRUTT et al. 2006; ZENG et al. 2005) as well as in Fz/PCP regulation, in particular CK1ε (KLEIN et al. 2006; STRUTT et al. 2006) and CK1α (STRUTT et al. 2006) . CK1 family members have been shown to phosphorylate Dsh (KLEIN et al. 2006; STRUTT et al. 2006) , and gish might act (at least) partially in a redundant manner in Dsh (core Fz/PCP) regulation and hence was identified in the screen. In addition, we observed two specific PCP-associated phenotypes with CG6963/gish knock down, which were also confirmed with LOF clones of existing mutant alleles. First, we detect a function in ommatidial rotation and ommatidial clusters appear to rotate less in gish mutant tissue.
This defect is accompanied by genetic interactions with Fz and Fmi among the core PCP genes.
Furthermore, gish interacts with nemo (MIRKOVIC et al. 2011) in this context in a specific manner:
Gish/CK1γ and Nemo act in opposition to each other (Fig. 9 ), suggesting that a fine balance between the activities of these two kinases is required for normal ommatidial rotation to occur. Second, gish/CG6963 knock down displays a high frequency of multiple cellular hairs, which is independent of a direct interaction with the core PCP factors (GAULT et al. 2012) .
The identification of CG15730 with a connection to PCP signaling is intriguing, as it encodes the Chirality and rotation defects were counted independently, negative controls did not modify sev-GAL4, UAS-dgo and GAL80 ts abolished the phenotype (F). Wing hair defects in sev-GAL4, UAS-pk are milder (C). (G) were assayed for genetic interaction, but showed no modification of either genotype. This left three genes near the centre of Df(2L)ED1315 that were not covered by any of the smaller deficiencies. We therefore tested these 3 genes and found that RNAi for CG31687 (an APC8 paralog) interacted similarly to Df(2L)ED1315 with the two screening genotypes, as did a P-element insertion KG10528
for CG2508(APC8/cdc23). Upper panels show tangential eye sections and lower panels show a schematic of ommatidial orientation (arrows) (compare Fig 1A for wild- Wing phenotypes such as wing hair orientation defects, multiple cellular hairs, and notches were observed. For wild-type wing compare Figure 2A , B. Red arrowheads point to margin or vein defects.
Wing hair orientation defects and multiple cellular hairs are indicated by arrows and circles, by CG15283 IR knock down. P values are for (E) * <.007, **<.003, and ***<0.0001 with n being 568-893 ommatidia in 4-5 eyes, and for (F) *<0.005 and **<0.001 with n being 536-806 ommatidia in 3-4 eyes. List of DrosDel deficiencies, which showed external modification of the dgo or pk induced PCP GOF phenotypes in the eye and/or wing, and their analysis by Rh1-GFP and wing hair orientation assessment.
Each DrosDel deficiency that showed an interaction was listed and strong interactors were analyzed further in detail for interaction with sev-GAL4, UAS-dgo and sev-GAL4, UAS-pk in the eye and wing.
Some interactions were tested repeatedly, indicated by 2x. Interactions were categorized as enhanced (enh), m= mildly, s=strongly, suppressed (su) or no interaction (no); n.d. = not determined. Rh1-GFP interactions were listed as enhanced or suppressed for rotation (rota) and/or chirality (chir) defects, and some effects were variable. Smaller deficiencies and individual genes, which confirmed original interactions.
The Drosdel and smaller deficiencies are listed in the first and second columns, respectively. The third column lists all genes that were tested by RNAi knockdown for PCP phenotypes. Genes that affected PCP when knocked down (compare Table 3 ) and reproduced the effects of the original deficiency are indicated in bold. Df(2L)ED62 and Df(3R)ED5642 covered ds and Dl, respectively (compare Suppl. Fig. 1 ).
Columns 4 and 5 list genes and the quality of their genetic interactions that reproduced the original genetic interactions with screen genotypes. Summary of PCP defects in the eye and wing of candidate genes studied.
The first two columns list the deficiency and gene/RNAi. Third column indicates potential vertebrate homologues and/or molecular function. Further columns indicate which GAL4 driver caused phenotypes. Rota = ommatidial rotation defects, chir = ommatidial chirality defects, hair ori = winghair orientation defects, mch = multiple cellular hairs, n.e. = no effect, and n.d. = not done 
